For in-vitro research only · Not for human use · 18+

Back to catalogue
Tesamorelin 20mg research peptide vial — Aussie Peptides
Incretin-class analogues

Product illustration — not a lot photograph or test evidence.

Tesamorelin — 20 mgResearch peptide

$269.00

per vial

In stock · 10 vials

Price is per single vial.

1

Laboratory research listing — not offered for human or veterinary use. Compliance

Details

Research overview

Tesamorelin (also catalogued as TH9507) is classified as: stabilised GHRH (1-44) analogue. Aussie Peptides lists it as a research reference material in a 20mg presentation. The identifiers below are drawn from public chemical references; batch-specific results are available only where a report for that lot has been published.

Reference data

Tesamorelin molecular information

Also known as
TH9507
Classification
Stabilised GHRH (1-44) analogue
Molecular formula
C221H366N72O67S
Average molecular mass
5135.9 g/mol
CAS number
218949-48-5
Look up Tesamorelin on PubChem

Batch documentation for Tesamorelin 20mg

No batch report is published online for this product yet. When one is, it will be matched to its lot number on the verify page. Check a lot number · How to read a batch report

Aussie Peptides brand mark

Aussie Peptides · specification

Tesamorelin — 20 mg

Labelled amount
20mg
SKU
TESAMORELIN-20MG
Batch report
Not published online
Handling data
Supplier SDS and your institutional SOP
Category
Incretin-class analogues

Batch results apply only to the lot they were measured on. Where a report has been published for your lot, it can be looked up on the verify page.

The Aussie Peptides label

Tesamorelin 20mg research peptide vial — Aussie Peptides

Product photos may show label text from an earlier design, including a printed purity figure. That figure is not a published batch result.

  • 1

    Brand mark

    The Aussie Peptides name and hexagon mark on a cream label with a coral spine.

  • 2

    Compound and labelled amount

    The compound name and labelled amount for that listing.

  • 3

    LOT and EXP fields

    Record the lot number; a batch report can only be matched to a lot if one has been published for it.

  • 4

    Research use only line

    Describes the intended use. It does not by itself determine regulatory status.

Batch documentation

Not published online for this product yet.

Look up a lot number · About batch reports

Laboratory handling

Handling & documentation

Aussie Peptides does not publish product- or lot-specific stability, storage-duration or preparation data for Tesamorelin — 20 mg. Base storage, reconstitution and disposal on the supplier safety data sheet (SDS) and your institution's standard operating procedures.

  • Record the lot number and expiry printed on the label when the item is received.
  • Check the verify page for a published batch report matching that lot.
  • Wear appropriate PPE and dispose of vials, sharps and unused material under your institution's waste procedures.

Ask by email if you need the supplier SDS for this item. Contact

No dosage advice

Aussie Peptides does not publish, supply or advise on human or veterinary dosing, administration or therapeutic use of any product, and nothing on this page should be read as such or as medical advice.

Products are listed for laboratory research and are not offered for human or animal consumption. A “research use only” label does not by itself determine regulatory status.

Shipping

Shipping within Australia. Rates are set out in the shipping policy and match checkout; courier delivery times are estimates, not guarantees.

Tesamorelin — strengths

Each option is a separate listing with its own labelled amount or combination. Batch reports, where published, apply only to the specific lot measured.

5mg vialEarlier listing
20mg vialLarger labelled amount · viewing now

Questions

Tesamorelin — 20 mg — frequently asked

What is Tesamorelin?+

Tesamorelin (also catalogued as TH9507) is classified as: stabilised GHRH (1-44) analogue. Aussie Peptides lists it as a research reference material in a 20mg presentation. The identifiers below are drawn from public chemical references; batch-specific results are available only where a report for that lot has been published.

Is a batch report published for Tesamorelin 20mg?+

Not at the moment. No batch report is published online for this product. Results belong to a specific lot; if a report is published later it will be matched to its lot number on the verify page, and you can ask by email whether one is available.

Check a lot numberHow to read a batch report

Where do I find storage and handling information for Tesamorelin?+

Aussie Peptides does not publish product- or lot-specific stability, storage-duration or preparation data for this item. Use the supplier safety data sheet (SDS) and your institution's standard operating procedures, and record the lot number printed on the vial.

What is the intended use of Tesamorelin?+

It is listed for laboratory research and is not offered for human or veterinary use. A “research use only” label does not by itself determine a product's regulatory status in Australia; the TGA explains how it regulates peptide products. Purchasers remain responsible for their own legal and institutional obligations.

Intended use and complianceTGA guidance on peptide products

How much is Tesamorelin 20mg and how is it shipped?+

The listed price is $269.00. The catalogue currently lists it as in stock. Current shipping rates and delivery estimates are set out in the shipping policy. Delivery times are courier estimates, not guarantees.

Shipping policy

Keep exploring

More from Incretin-class analogues